• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breast-feeding. There aren't enough data regarding how exposure over time may affect a fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the foetus. Physicians don't have the data to make unambiguous recommendations however they can provide information on the risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications during their early pregnancy did not have an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a large sample-based case control study to compare the incidence of major structural defects in infants born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists examined the cases to ensure accurate case classification and to minimize the possibility of bias.

However, the researchers' study had its limitations. The researchers were unable in the beginning to distinguish the effects caused by the medication for adhd and anxiety from the disorder. This makes it difficult to know whether the small differences observed in the exposed groups result from medication use or confounding by comorbidities. In addition, the researchers did not study the long-term outcomes of offspring.

The study showed that infants whose mother had taken ADHD medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy or stopped taking their medication before or during pregnancy. This was due to central nervous system disorders, and the increased risk for admission was not found to be affected by the type of stimulant medications were used during pregnancy.

Women who used stimulant ADHD medication during pregnancy were also at an increased risk of having a caesarean section or having a baby born with an low Apgar score (less than 7). These risks did not seem to be influenced by the kind of medication used during pregnancy.

Researchers suggest that the small risk of using ADHD medications during early pregnancies could be offset by the greater benefits to both baby and mother of continued treatment for the woman's condition. Physicians should discuss this with their patients and, when possible, assist them in developing strategies for improving their coping skills which can reduce the impact of her disorder on her daily functioning and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently made without clear and reliable evidence. Instead, doctors must weigh their own knowledge and experience, as well as the experiences of other doctors and the research on the topic.

The issue of potential risks to infants is extremely difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and a lot of the results are contradictory. In addition, most studies limit their analysis to live births, which could underestimate severe teratogenic effects that result in abortion or termination of the pregnancy. The study presented in this journal club addresses these shortcomings by examining data on both live and deceased births.

Conclusion: While some studies have shown a positive correlation between ADHD medications and certain birth defects however, other studies haven't shown such a relationship. Most studies have shown a neutral, or even slight negative effect. In each case an in-depth analysis of the potential risks and benefits should be conducted.

For many women with ADHD who suffer from ADHD, the decision to stop medication can be difficult, if not impossible. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of isolation. Additionally, the loss of medication can interfere with the ability to complete work-related tasks and safely drive that are crucial aspects of a normal life for a lot of people with ADHD.

She suggests women who are unsure about whether to keep or stop medication in light of their pregnancy consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily life, and the advantages of staying on the current treatment regimen. It can also help women feel confident about her decision. It is also worth noting that certain medications are able to pass through the placenta, so if a woman decides to stop taking her liquid adhd medication medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug could be transferred to the child.

Birth Defects and Risk of

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (safest adhd medication) grows as do concerns about what impact the drugs might have on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing information on this topic. Researchers utilized two massive data sets to examine over the counter adhd medication for adults 4.3 million pregnant women and determine if stimulant medication use increased the risk of birth defects. Although the risk overall remains low, the scientists did find that first-trimester exposure to ADHD medications was associated with an increased risk of specific heart defects, like ventriculo-septal defects (VSD).

The authors of the study could not discover any link between early use of medication and other congenital anomalies, such as facial deformities or club feet. The results are consistent with previous studies revealing an increase, but not significant, in the risk of heart malformations in women who started taking ADHD medications before the time of pregnancy. This risk increased in the latter half of pregnancy, when a lot of women are forced to stop taking their ADHD medication.

Women who took ADHD medication in the first trimester were more likely require a caesarean birth, have a low Apgar after delivery, and have a baby that needed help breathing when they were born. However the authors of the study were not able to eliminate selection bias by restricting the study to women who did not have any other medical issues that could have contributed to these findings.

The researchers hope their study will aid in the clinical decisions of doctors who encounter pregnant women. They recommend that, while the discussion of the risks and benefits is crucial however, the decision to stop or keep medication must be based on each woman's needs and the severity of her ADHD symptoms.

The authors warn that, while stopping the medication is a possibility to think about, it isn't recommended due to the high rate depression and other mental disorders for women who are pregnant or who have recently given birth. Additionally, research suggests that women who stop taking their medications will have a harder adjustment to life without them after the baby is born.

Nursing

It can be overwhelming becoming a mother. Women with ADHD who have to deal with their symptoms while attending physician appointments as well as making preparations for the arrival of their child and adapting to new routines in the home may face a lot of challenges. As such, many women choose to continue taking their ADHD medications throughout the course of pregnancy.

The majority of stimulant drugs pass through breast milk in small quantities, so the risk to the breastfeeding infant is minimal. The rate of exposure to medication will differ based on dosage the medication is administered, its frequency and the time of the day. In addition, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn is not yet fully known.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication against the potential dangers to the foetus. Until more information becomes available, GPs can ask pregnant patients if they have any background of ADHD or if they plan to take medication in the perinatal stage.

Numerous studies have proven that women can continue to take their ADHD medication without risk while breastfeeding and during pregnancy. This has led to more and more patients choose to do so, and in consultation with their doctor they have discovered that the benefits of maintaining their current medication outweigh any potential risks.

It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their physician and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from adhd medication pregnancy (Www.tianxiaputao.com) be aware of the symptoms and underlying disorder. They should also be educated about treatment options and build the coping mechanisms. This should involve a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. The pregnancy counselling should consist of discussion of a management plan for both mother and child, and monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.